Premium Insight of Global Nuclear Medicine Market 2021-2027

Report ID: BMRC 53 | Number of pages: 200 | Publish Date: May 2019 | Publisher: BMRC | Category: Chemicals and Materials
Our final report will cover impact analysis of COVID-19 outbreak
New
Brandessence Market Research is working on a new report title“Global Nuclear Medicine Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027?. Growing demand for advanced and accurate diagnostic techniques and effective treatment are fueling the market growth. Additionally, increasing incidences of cancer and cardiac ailments likely to enhance the growth of Global Nuclear Medicine Market.

Scope of Global Nuclear Medicine Market Reports –
Nuclear medicine is a branch of medical imaging which uses very small amount of radioactive material (Radiopharmaceuticals) to diagnose and treat variety of disease such as various forms of cancers, heart disease, gastrointestinal, endocrine, neurological disorders, and other abnormalities within the body.In Nuclear Medicine imaging the radioisotopes are identified by the special type of cameras connected to the computer which offersactualimage of the body part which was examined. Nuclear Medicines are radioactive materials that are injected into bloodstream or are swallowed in small amount through which they can help in early detection of diseases. By using radioactive material with pharmaceutical compounds used to detect a definite organ for imaging purposes, to check the development of disease in the body, concentrating on cellular function and physiology of the body. Nuclear medicine includes treatment of diseased tissues. Therapeutic nuclear medicines or used to treat an overactive thyroid gland – a condition known as hyperthyroidism or thyrotoxicosis.

Nuclear Medicine helps to find medical information that is not easily available or requires surgical procedure or costly and invasive diagnostic tests. It helps in detection of symptoms at a very early stage of a disease.

Global Nuclear Medicine Market has been segmented on the basis of Type, Procedural Volumes, Application, End User and Geography. On the basis ofType of Global Nuclear Medicine Market is classified into Diagnostic Nuclear Medicine,Therapeutic Nuclear Medicine, Research Nuclear Medicine and Other.On the basis of Procedural Volumes of Global Nuclear Medicine Market is classified intoDiagnostic Procedures,Therapeutic Procedures and Other.On the basis of ApplicationGlobal Nuclear Medicine Market is classified intoOncology,Cardiology, Neurology, Thyroid, Lymphoma, Endocrinology and others.On the basis of End User Global Nuclear Medicine Market is classified intodiagnostic centers, hospitals, research centers and others.  The regions covered in Global Nuclear Medicine Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Nuclear Medicine Market Reports –
Global Nuclear Medicine Market reports cover prominent players like Cardinal Health Inc., Mallinckrodt plc, GE Healthcare, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.p.A, Eczacibasi-Monrol Nuclear Products, Advanced Accelerator Applications S.A., IBA Molecular Imaging, Mallinckrodt plc, Cardinal Health Inc., Curium, Lantheus Medical Imgaging, Triad Isotopes, Siemens Healthineer, Bracco, Cambridge Isotope Laboratories Inc., Nordion Inc., Fujifilm Holdings Corporation, Philips Healthcare, Digirad, Ashby Gorman Baker Ltd, Lantheus Medical Imaging Inc., Jubilant Life Sciences and NTP Radioisotopes SOC Ltd.

Global Nuclear Medicine Market Dynamics –
Growth of the overallGlobal Nuclear Medicine Market can be attributed to factors such as the increasing incidences of cancer and cardiovascular disorders, development of alpha radiotherapy and funds through public-private partnerships.Growing occurrence of cardiac patients and acceptance of clear imaging method, with the help of diagnostic equipment such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography). Moreover, themanufacture of MO-99 in the U.S. approval of Nuclear Medicine by the FDA, new irradiation capacity in Germany, system of PET scanners in India, funds by the government in the Rest of Asia-Pacific and initiatives of IAEA (International Atomic Energy Agency) is enhancing theGlobal Nuclear Medicine Market.The factors that restrain the growth of the Global Nuclear Medicine Market includeHigh cost of medicinessuch asmore than $100 million, supply shortages, logistical difficulties and limited number of trained medical personnel.Also, stringent government regulation for drug approval are keyreasonshindering growth of the Global Nuclear Medicine Market.Furthermore, reimbursement obstacles for the manufacturer and high money investment are also restraining the Global Nuclear Medicine Market growth. Moreover, advancements in scanning technology are increasing the effectiveness of diagnosis using radioisotopes and as a consequence application areas of current radioisotopes are quickly growing. Extensiveuses of the existing products united with introduction of newer radioisotopes for the diagnosis of respiratory, bones and thyroid related diseases are increasing the growth of nuclear medicines in the Global Nuclear Medicine Market.

High accurateness, capacity to integrate with other diagnostic techniques such as x-ray and growing awareness of this technique in the developing market are the main factors likely to fuel the market growth of the diagnostic nuclear medicines during the forecast period.

Global Nuclear Medicine Market Regional Analysis –
From a geographical standpoint, North America is the dominant market in 2017and occupied around 40% of the overall market revenue. In North America the United States is the major consumer market for Nuclear Medicine and Canada is the largest producer of Tc-99m.It is due to the widespread awareness of the use of radioisotopes and radiation in medicine for various medical conditions. In the developed countries, the frequency of diagnostic and therapeutic nuclear medicine is rising exponentially. Asia Pacific is projected to outshine all other regions in the upcoming years, mainly driven by Japan, China, Australia, and India nations where the fastest growth in the region are rising healthcare spending and increasing awareness of Nuclear Medicine among healthcare providers. The huge population, increasing occurrences of neurological and cardiovascular diseases as well as various types of cancer is also contributory to the growth of Global Nuclear Medicine Market in Asia Pacific.

Key Benefits for Global Nuclear Medicine Market Reports –
Global Nuclear Medicine Market report covers in depth historical and forecast analysis.
Global Nuclear Medicine Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global Nuclear Medicine Market report helps to identify opportunities in market place.
Global Nuclear Medicine Market report covers extensive analysis of emerging trends and competitive landscape.

Global Nuclear Medicine Market Segmentation–
Global Nuclear Medicine Market: By Type Analysis
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Research Nuclear Medicine
Other
Global Nuclear Medicine Market: By Procedural Volumes Analysis
Diagnostic Procedures
Therapeutic Procedures
Other
Global Nuclear Medicine Market: By Application Analysis
Oncology
Cardiology
Neurology
Thyroid
Lymphoma
Endocrinology
Other
Global Nuclear Medicine Market: By End User Analysis
Diagnostic Centres
Hospitals
Research Centres
Other
Global Nuclear Medicine Market: By Regional & Country Analysis
North America
U.S.
Mexico
Canada
Europe
UK
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
The Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Interested in this report?
Get your sample now!
Table of Content

Chapter – Report Methodology
Research Process
Primary Research
Secondary Research
Market Size Estimates
Data Triangulation
Forecast Model
USP’s of Report
Report Description
Chapter – Global Nuclear Medicine Market Overview: Qualitative Analysis
Market Introduction
Executive Summary
Global Nuclear Medicine Market Classification
Market Drivers
Market Restraints
Market Opportunity
Global Nuclear Medicine Market: Trends
Porter’s Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Consumers
Threat of New Entrants
Threat of Substitute Product and Services
Competitive Rivalry within the Industry
Market Attractiveness Analysis
Market Attractiveness Analysis by Segmentation
Market Attractiveness Analysis by Region
Chapter – Global Nuclear Medicine Market Overview: Quantitative Analysis
Global Nuclear Medicine Market Production (K Unit), Market Share (%) and Growth Rate (%), 2021- 2027
Global Nuclear Medicine Market Consumption (K Unit), Market Share ( %) and Growth Rate, 2021- 2027
Global Nuclear Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2021- 2027
Chapter –Global Nuclear Medicine Market: by Type
Chapter –Global Nuclear Medicine Market: by Procedural Volumes
Chapter –Global Nuclear Medicine Market: by Application
Chapter –Global Nuclear Medicine Market: by End User
Global Nuclear Medicine Market (USD Million), by Manufacturer, 2021 – 2027
Global Nuclear Medicine Market Production (K Unit), by Manufacturer, 2021 – 2027
Global Nuclear Medicine Market Consumption (K Unit), Manufacturer, 2021 – 2027
Global Nuclear Medicine Market Share (%), by Manufacturer, 2027
Global Nuclear Medicine Market Price (USD/Unit), by Manufacturer, 2021 – 2027
Global Nuclear Medicine Market Revenue Growth Rate (%), by Manufacturer, 2021 – 2027
Merger & Acquisition
Collaborations and Partnership
New Product Launch
Chapter -Global Nuclear Medicine Market: Regional Analysis
North America
North America Global Nuclear Medicine Market Revenue (USD Million) and Growth Rate (%), 2021 – 2027.
North America Global Nuclear Medicine Market Revenue (USD Million) By Country, 2021 – 2027.
North America Global Nuclear Medicine Market Revenue Market Share (%) By Country, 2021 – 2027.
North America Global Nuclear Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2021 – 2027.
North America Global Nuclear Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2021 – 2027.
North AmericaGlobal Nuclear Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2021 – 2027.
Europe
Asia Pacific
Latin America
Middle East & Africa
Chapter – Company Profiles
Advanced Accelerator Applications S.A.
Overview
Financials
Product portfolio
Global Nuclear Medicine Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2021 – 2027
Global Nuclear Medicine Market Share (%), 2021 – 2027
Business Overview
Ashby Gorman Baker Ltd
Bayer AG
Bracco Imaging S.p.A
Cambridge Isotope Laboratories Inc.
Cardinal Health Inc.
Curium
Digirad
Eczacibasi-Monrol Nuclear Products
Fujifilm Holdings Corporation
GE Healthcare
IBA Molecular Imaging
Jubilant Life Sciences
Lantheus Medical Imaging Inc.
Mallinckrodt plc
Nordion Inc.
NTP Radioisotopes SOC Ltd.
Philips Healthcare
Siemens Healthineer
Triad Isotopes
Other
Chapter – Market Research and Findings
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.